Press Releases

Press Releases

All Releases
Feb 28, 2017
- Conference Call and Webcast Today, February 28 , at 8:00 a.m. ET - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced financial and operating results for the fourth quarter and full year ended December 31, 2016 and provided a general business update.
Feb 22, 2017
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report its fourth quarter and full year 2016 financial and operating results on Tuesday, February 28, 2017 . Following the announcement, Ophthotech's management team will host a live conference call and
Feb 01, 2017
- Plan Designed to Evaluate Strategic Alternatives and Maximize Shareholder Value - - Announces Executive Changes: Glenn P. Sblendorio Assumes the Position of President and Keith Westby Takes on the Role of Chief Operating Officer - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT)
Dec 12, 2016
No benefit observed upon addition of Fovista ® to monthly Lucentis ® regimen for the treatment of wet age-related macular degeneration - Conference Call and Webcast Today, December 12, 2016 at 8:30 a.m. ET - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today
Nov 08, 2016
- Conference Call and Webcast Today, November 8 th , at 8:00 a.m. ET - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq: OPHT) today announced financial results for the third quarter ended September 30, 2016 and provided an update on the Company's business and product development
Oct 31, 2016
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced that the Phase 2b study results of Fovista ® (pegpleranib), the Company's anti-PDGF agent administered in combination with Lucentis ® (ranibizumab) anti-VEGF therapy for the treatment of wet age-related
Oct 24, 2016
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report its third quarter financial results on Tuesday, November 8, 2016 . Following the announcement, Ophthotech's management team will host a live conference call and webcast at 8:00 a.m.
Sep 06, 2016
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present at the Morgan Stanley Global Healthcare Conference in New York, NY on
Aug 03, 2016
- Conference Call and Webcast Today, August 3 rd , at 8:00 a.m. ET - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced financial results for the second quarter ended June 30, 2016 and provided an update on the Company's business and product development programs.
Aug 02, 2016
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced the election of Ian F. Smith , Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals, to its Board of Directors, effective immediately. Mr. Smith has also been elected the Chair of the
Jul 25, 2016
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq: OPHT) today announced that it will report its second quarter 2016 financial results on Wednesday, August 3, 2016 . Following the announcement, Ophthotech's management team will host a live conference call and webcast at 8:00 a.m.
Jun 20, 2016
- $30 Million Milestone Triggered by Reaching Final Enrollment Goal in the Third Phase 3 Trial in the Fovista ® Program - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq: OPHT) today announced the completion of patient recruitment in its Phase 3 trial of Fovista ®
May 31, 2016
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present at the Goldman Sachs 37 th Annual Global Healthcare Conference in Rancho
May 04, 2016
- Conference Call and Webcast Today, May 4 th , at 8:00 a.m. ET - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced financial results for the first quarter ended March 31, 2016 and provided an update on the Company's business and product development programs.
Apr 28, 2016
- Globally Recognized Innovator and Distinguished Scholar in the Diagnosis and Treatment of Retinal Disorders - - Brings Extensive Organizational and Leadership Experience - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation ( NASDAQ : OPHT) announced today the appointment of Carmen A.
Apr 26, 2016
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report its first quarter 2016 financial results on Wednesday, May 4, 2016 . Following the announcement, Ophthotech's management team will host a live conference call and webcast at 8:00 a.m.
Mar 08, 2016
Webcast Available Through Ophthotech Website NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the Barclays Global Healthcare Conference 2016 in
Feb 24, 2016
- Conference Call and Webcast Today, February 24 , at 8:00 a.m. ET - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq:OPHT) today announced financial results for the fourth quarter and full year ended December 31, 2015 and provided an update on the Company's business and product
Feb 18, 2016
- Webcast Available Through Ophthotech Website - NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the RBC Capital Markets Healthcare Conference
Feb 17, 2016
NEW YORK --(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq: OPHT) today announced that it will report its fourth quarter and year ended December 31, 2015 financial results on Wednesday, February 24, 2016 . Following the announcement, Ophthotech's management team will host a live conference call